How do you develop new therapies harnessing genomics and proteomics when effective lipid-lowering drugs are now almost free? Check out our recent webinar with Jessica van Setten (University Medical Center Utrecht), Floriaan Schmidt (University College London) and Adam Butterworth (University of Cambridge) on this topic.